IOVA

Iovance Biotherapeutics Inc (IOVA)

US
$ 3.56-1.93%

Price Chart

Key Statistics

Market Cap
$ 564.35M
P/E Ratio
0.00
Revenue (TTM)
$ 212.68M
Volume
8.26M
52W High
$ 12.51
52W Low
$ 1.64
Dividend Yield
0.00%
Beta
0.86

Technicals

50-Day MA
2.3472
200-Day MA
6.0047
52 Week High
12.51
52 Week Low
1.64

About IOVA

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic m.

Employees
838
Headquarters
San Carlos, CA
CEO
Dr. Frederick G. Vogt Esq., J.D., Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
UGP
Ultrapar Participac...
$ 3.39
9.00
JNPR
Juniper Networks In...
$ 39.91
8.39
RDDT
Reddit Inc. Class A...
$ 153.01
6.98
CVNA
Carvana Co. Class A...
$ 336.98
5.64
WHR
Whirlpool Corporati...
$ 101.01
5.03

Top Losers

Symbol/Name
LTP
% Chg
CHPT
ChargePoint Holding...
$ 0.71
-5.33
WCC
WESCO International...
$ 176.52
-4.87
RMAX
RE/MAX Holdings Inc...
$ 8.18
-3.76
LEG
Leggett & Platt Inc...
$ 8.92
-3.46
NOG
Northern Oil and Ga...
$ 28.04
-3.24